Your browser doesn't support javascript.
loading
Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis: Review of Published Cases.
Roukain, Abdallah; La Rosa, Stefano; Bongiovanni, Massimo; Nicod Lalonde, Marie; Cristina, Valérie; Montemurro, Michael; Cochet, Stephane; Luquain, Alexandra; Kopp, Peter A; Sykiotis, Gerasimos P.
Affiliation
  • Roukain A; Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • La Rosa S; Institute of Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Bongiovanni M; Synlab Pathology, 1003 Lausanne, Switzerland.
  • Nicod Lalonde M; Service of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Cristina V; Service of Medical Oncology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Montemurro M; Service of Medical Oncology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Cochet S; Centre de Chimiothérapie Anti-Cancéreuse CCAC SA, Av. Alexandre Vinet 19b, 1004 Lausanne, Switzerland.
  • Luquain A; Cypa Pathology, Unilabs, 1066 Lausanne, Switzerland.
  • Kopp PA; Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Sykiotis GP; Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Cancers (Basel) ; 13(17)2021 Sep 06.
Article in En | MEDLINE | ID: mdl-34503292
ABSTRACT
Desmoid-type fibromatosis (DTF) is a very rare variant of papillary thyroid carcinoma (PTC). It is essentially a dual tumor with a component of classical PTC with malignant epithelial proliferation (BRAF-mutated) and another component of mesenchymal proliferation (CTNNB1-mutated). We conducted a literature review on PTC-DTF. In total, 31 articles were identified, that together reported on 54 patients. The mean age was 47 years, with a 2.21 female predominance. No ultrasound features were found to be helpful in differentiating PTC-DTF from other PTC variants. Of the 43 cases that reported histological details, 60% had locally infiltrative disease (T3b or T4). Around 48% had cervical lymph node metastases, but none had distant metastases. While PTC-DTF may be locally more aggressive than classic PTC, its overall behavior is similar and can include extrathyroidal extension and lymph node metastases, which may contain a stromal component and show extranodal invasion. The mainstay of treatment for PTC-DTF is surgery, and the DTF component is not expected to be sensitive to radioactive iodine. External radiotherapy, non-steroidal anti-inflammatory drugs, tyrosine kinase inhibitors and chemotherapy have also been used in selected cases. Due to the rarity of these tumors and the lack of specific treatment guidelines, management should be discussed in a multidisciplinary team.
Key words

Full text: 1 Database: MEDLINE Type of study: Guideline / Systematic_reviews Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Type of study: Guideline / Systematic_reviews Language: En Year: 2021 Type: Article